Skip to main content
EXO-END • RESEARCH USE ONLY

Endothelial Exosomes

Derived from vascular endothelial cells; these exosomes include angiogenic signals and vascular homeostasis mediators.

Product image for an exosome product from Akira Biotech
Vascular homeostasis
ENDOTHELIAL EV IDENTITY
— Sourced from endothelial cells lining vessels and carrying angiogenic plus barrier-regulatory mediators that tune permeability and tone.
Neo-angiogenesis
ISCHEMIA RESPONSE
— Stimulates new vessel networks in ischemic limbs, stroke penumbra, and chronic wound beds while calming endothelial activation.
Microvascular fidelity
PERIPHERAL & SPECIALIZED BEDS
— Extends to microvascular repair, hypertension-related remodeling research, and penile perfusion / erectile function investigation.
ROUTES, FORMATS & APPLICATIONS
Routes
TBATBA
Quantities
400 Billion Exosomes1ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Peripheral Artery Disease
  • Ischemic Stroke
  • Hypertension
  • Erectile Dysfunction
  • Wound healing
  • Microvascular repair

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup